VIRAL NEWS

BusinessNEWSVIRAL NEWS

The United States pharmaceutical industry entered a new phase of government intervention after President Donald Trump announced a landmark agreement with Regeneron Pharmaceuticals. The deal, centered on the Trump drug price deal Regeneron, marks the final agreement in a broader initiative involving 17 major pharmaceutical companies under the administration’s “Most Favored Nation” (MFN) pricing strategy.

The announcement, made on April 23, 2026, signals a continued push by the White House to reduce prescription drug costs

Read More
BusinessNEWSVIRAL NEWS

The Intel Earnings 2026 report has sent shockwaves across the tech and financial world, signaling a powerful turnaround for the semiconductor giant after years of uncertainty. Under CEO Lip-Bu Tan, Intel is not just recovering—it is redefining its identity by returning to what leadership calls its “paranoid” engineering-driven roots.

This renewed mindset appears to be working. The company delivered stronger-than-expected quarterly results, sparking a surge in its stock and

Read More